NCT05691569

Brief Summary

Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers severely reducing their quality of life. BPSD worsen during hospitalization and require the administration of psychotropic drugs that are often insufficient to control the symptoms, and may cause severe adverse events. The investigators propose the use of empathy dolls in order to reduce BPSD and in particular agitation and aggressiveness in acute geriatric in-patients affected by moderate to severe forms of dementia. The use of doll therapy in the clinical routine will allow to reduce the use of psychotropic drugs, shorten hospitalization, reduce professional and family caregiver burden improving patients' and families' quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
16mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Nov 2024Aug 2027

First Submitted

Initial submission to the registry

November 29, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
1.8 years until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

2.4 years

First QC Date

November 29, 2022

Last Update Submit

April 7, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • agitation and aggressiveness within hospital

    measured by Pittsburgh Agitation Scale (PAS). the score ranges between 0 to 16 on the PAS the higher score means the higher agitation

    baseline and hospital discharge discharge (up to one week)

  • behavioural and psychological symptoms of dementia

    Neuro Psychiatic Inventory (NPI). The NPI total score ranges from 0 to 144, higher scores means more severe and frequent behavioural and psycological symptoms of dementia

    baseline, discharge (up to one week)

  • agitation and aggressiveness outside hospital

    Cohen Mansfield Inventory scale (CMAI). the score ranges betwen 0 and 203, with higher scores indicating more agitation

    baseline, 1 and 4 weeks after discharge

Secondary Outcomes (5)

  • incidence of delirium

    every day during hospital stay (up to one week)

  • patients' quality of life

    baseline and 4 weeks after discharge

  • family caregivers' quality of life

    baseline and 4 weeks after discharge

  • professional caregiver burden

    baseline and at hospital discharge (up to one week)

  • family caregiver burden

    baseline and 4 weeks after discharge

Study Arms (2)

doll therapy

EXPERIMENTAL

The doll used in the study is the "empathy doll"; these dolls are designed to obtain an optimal interaction with patients and to arouse empathy

Other: doll therapy

non anthropomorphic object

OTHER

non- anthropomorphic soft object

Other: doll therapy

Interventions

empathy dolls

doll therapynon anthropomorphic object

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • age ≥65 years
  • diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2
  • presence of agitation and/or aggressiveness
  • manual and visual abilities sufficient in order to interact with the doll.

You may not qualify if:

  • age \<65 years;
  • refuse to participate;
  • mild forms of dementia (CDR\<2);
  • contraindication for DT as experience of mournful or traumatic events related to parental experience;
  • life expectancy lower than 3 months;
  • infectious diseases requiring isolation;
  • negative interaction with the doll,
  • presence of delirium.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

geriatric and Geriatric Rehabilitation Unit

Lausanne, Canton of Vaud, 1011, Switzerland

RECRUITING

Related Publications (5)

  • Martin-Garcia A, Corregidor-Sanchez AI, Fernandez-Moreno V, Alcantara-Porcuna V, Criado-Alvarez JJ. Effect of Doll Therapy in Behavioral and Psychological Symptoms of Dementia: A Systematic Review. Healthcare (Basel). 2022 Feb 23;10(3):421. doi: 10.3390/healthcare10030421.

    PMID: 35326899BACKGROUND
  • Molteni V, Vaccaro R, Ballabio R, Ceppi L, Cantu M, Ardito RB, Adenzato M, Poletti B, Guaita A, Pezzati R. Doll Therapy Intervention Reduces Challenging Behaviours of Women with Dementia Living in Nursing Homes: Results from a Randomized Single-Blind Controlled Trial. J Clin Med. 2022 Oct 24;11(21):6262. doi: 10.3390/jcm11216262.

    PMID: 36362489BACKGROUND
  • James IA, Reichelt K, Shirley L, Moniz-Cook E. Management of Agitation in Behaviours That Challenge in Dementia Care: Multidisciplinary Perspectives on Non-Pharmacological Strategies. Clin Interv Aging. 2023 Feb 18;18:219-230. doi: 10.2147/CIA.S399697. eCollection 2023.

    PMID: 36843632BACKGROUND
  • Peng Y, Liu Y, Guo Z, Zhang Y, Sha L, Wang X, He Y. Doll therapy for improving behavior, psychology and cognition among older nursing home residents with dementia: A systematic review and meta-analysis. Geriatr Nurs. 2024 Jan-Feb;55:119-129. doi: 10.1016/j.gerinurse.2023.10.025. Epub 2023 Nov 19.

    PMID: 37980780BACKGROUND
  • Santagata F, Massaia M, D'Amelio P. The doll therapy as a first line treatment for behavioral and psychologic symptoms of dementia in nursing homes residents: a randomized, controlled study. BMC Geriatr. 2021 Oct 12;21(1):545. doi: 10.1186/s12877-021-02496-0.

    PMID: 34641791BACKGROUND

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Patrizia D Amelio, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled open label trial with two parallel arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full professor, head of the geriatric and Geriatric rehabilitation Service

Study Record Dates

First Submitted

November 29, 2022

First Posted

January 20, 2023

Study Start

November 15, 2024

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations